Artin Bioscience Inc.

DENVER, CO · Founded 2021 · CIK 0001968329 · Medtech

Inhalation therapy platform for respiratory diseases

artinbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$483K
1 Form D · Mar 2023
43 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$482,500
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1498VIROLOCK TECHNOLOGIES LIMITED LIABILITY COMPANY——
1499Endolumik, Inc.—$2.2M
1500PENDERIA TECHNOLOGIES, INC.—$65K
1501Artin Bioscience Inc.—$483K
1502Eye Care International LLC—$2.1M
1503Persist Inc.—$30K
1504VOLATYLIX INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • David DoyleDirector · Executive Officer
  • Erik EgliteDirector · Executive Officer
  • Charles MagolskeDirector · Executive Officer
  • Norbert VoelkelDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.